Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06013579 · ClinicalTrials.gov registry record · NA

Effect of High-Intensity Exercise to Attenuate Cognitive Function Limitations and Train Exercise Habits in Older People Living With HIV

A NA study of HIV Infections and Cognitive Impairment, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
110
Enrollment target
3
Study locations

NCT06013579: Recruiting NA study of HIV Infections and Cognitive Impairment, sponsored by University of Alabama at Birmingham.

NCT06013579 is a NA study of HIV Infections and Cognitive Impairment that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 110 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (75% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06013579, a NA study of HIV Infections and Cognitive Impairment, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
110 participants
Enrollment target
3
Study locations

Study Summary

People aging with HIV are at higher risk for Alzheimer's disease and related dementias, and although physical activity is a promising target to mitigate such risk, this population engages in low levels of physical activity. Few studies have tested cognitive effects of exercise interventions or examined mechanisms of adherence to long-term exercise among diverse samples of midlife and older people with HIV. The current study will leverage an existing R01 to address these gaps and provide implications for development of personalized approaches for the treatment and prevention of cognitive impairment and dementia in older people with HIV.

Primary Outcome

Cognitive assessment battery test speed of processing, learning, memory, executive functioning, verbal fluency, working memory, motor, subjective cognitive complaints, and everyday functioning.

Interventions

  • BEHAVIORAL Phase 1 Gym Exercise HIIT
  • BEHAVIORAL Phase 1 Gym Exercise CME
  • BEHAVIORAL Phase 2 Home Exercise Coaching Text Messages
  • BEHAVIORAL Phase 2 Home Exercise Control Text Messages

Study Locations (3)

Alabama

  • University of Alabama at Birmingham - Birmingham

Colorado

  • University of Colorado Denver - Aurora

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2023-08-01
Est. Completion 2028-03
Phase NA
University of Alabama at Birmingham

1,160 total trials

What NCT06013579 shows while recruiting

NCT06013579 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (75% lower).

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 4 interventions - of which Phase 1 Gym Exercise HIIT is the first listed.

NCT06013579 reports a single indexed study location in Alabama, Colorado, Washington.

Frequently Asked Questions

What is clinical trial NCT06013579 about?

NCT06013579 is a clinical study titled "Effect of High-Intensity Exercise to Attenuate Cognitive Function Limitations and Train Exercise Habits in Older People Living With HIV". People aging with HIV are at higher risk for Alzheimer's disease and related dementias, and although physical activity is a promising target to mitigate such risk, this population engages in low levels of physical activity. Few studies have tested cognitive effects of exercise interventions or exami...

What is the current status of trial NCT06013579?

This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2023-08-01. Estimated completion is 2028-03.

What conditions does trial NCT06013579 study?

This clinical trial studies the following conditions: HIV Infections, Cognitive Impairment.

What interventions are being tested in trial NCT06013579?

The interventions under investigation include: Phase 1 Gym Exercise HIIT (BEHAVIORAL), Phase 1 Gym Exercise CME (BEHAVIORAL), Phase 2 Home Exercise Coaching Text Messages (BEHAVIORAL), Phase 2 Home Exercise Control Text Messages (BEHAVIORAL).

Who is sponsoring clinical trial NCT06013579?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06013579 being conducted?

This trial has 3 study locations across Alabama, Colorado, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06013579's enrollment target sits among peer trials

110 254th of 542 higher than 289 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06013579, the US trial registry maintained by the National Library of Medicine. NCT06013579 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.